Documente Academic
Documente Profesional
Documente Cultură
The Wto's Use of Relevant Rules of International Law: An Analysis of the Biotech Case
Author(s): Margaret A. Young
Source: The International and Comparative Law Quarterly, Vol. 56, No. 4 (Oct., 2007), pp. 907930
Published by: Cambridge University Press on behalf of the British Institute of International and
Comparative Law
.
JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of
content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms
of scholarship. For more information about JSTOR, please contact support@jstor.org.
Cambridge University Press and British Institute of International and Comparative Law are collaborating with
JSTOR to digitize, preserve and extend access to The International and Comparative Law Quarterly.
http://www.jstor.org
Current Developments
907
II. THEWTO'SUSEOFRELEVANT
RULESOFINTERNATIONAL
LAW:
AN ANALYSISOFTHEBIOTECH
CASE
A. Introduction
Therelationship
betweentradeandotherareasof international
lawis highlycontested.
Some observerssuggestthatthe enforceability
of WorldTradeOrganization
(WTO)
to furtherothergoalssuchas environmental
obligationsshouldbe harnessed
protection
or humanrights.Othersarguethatimposingconditionsof thiskindcanallowprotectionistStatesto subverttheiragreedtradecommitments.
Still othersrespondthatthe
kindof 'self-contained
issuesoutsideof
regime'thatis necessaryto keep 'non-trade'
the WTOis antithetical
to the ideaof an 'international
legalsystem'.Thisdebatehas
beenplayedout in manylocations.TheInternational
LawCommission,for example,
the
nature
of
international
law, in whichfragmented
recentlyemphasized systemic
normsareresolvablethroughtreatyinterpretation
andotherrules.1
In EC-MeasuresAffectingthe Approvaland Marketingof Biotech Products a WTO
andin standard-setting
bodiesliketheCodexAlimentarius
andin international
organizationslike the FoodandAgricultural
(FAO).Oneissue for the Panel,
Organization
then, was how to take accountof this international
legal contextin resolvingthe
dispute.Thisissuewasmademoredifficultbecausesomeof thedisputingpartieswere
notpartiesto thetreatiesthatformedthisinternational
context--theEC,for example,
was the only disputingpartythat had signed and ratifiedthe BiosafetyProtocol.
therelevantnorms.
Varyingdegreesof Stateconsentthereforeaccompanied
ThePanelresponded
by distinguishing
strictlybetweenbindingapplicablelaw and
'informative'
lawthatcouldbe takenintoaccountin interpreting
therelenon-binding
vantWTOagreements.5
In doing so, the PanelconstruedArticle31(1) andArticle
of the StudyGroupof the International
LawCommission
as finalizedby the
1 Report
M Koskenniemi,
of International
Law:DifficultiesArisingfromthe
Chairman,
'Fragmentation
andExpansion
Diversification
of International
Law'ILC,UN Doc,A/CN.4/L.682
andCorr.1and
Add. 1 (13 Apr 2006). The UN GeneralAssemblytook note of the conclusionsof the
Commission'sStudyGroup,togetherwiththe analyticalstudyfinalizedby the Chairman,
on 4
December2006:see UN Doc A/Res/61/34.
2 PanelReportWT/DS291/R,
29 Sept2006(Biotech).
WT/DS292/R,
WT/DS293/R,
3 TheBiotechpanelusedtheterms'biotechproducts','GMOs','GMplants','GMcrops'or
'GMproducts'interchangeably:
see paras7.1-7.2. I haveadoptedthe sameapproach,
although
'biotech'is botha widertermandone whichpotentiallyobfuscatesthe issuesby removingthe
politicallychargedlanguageof 'GM'fromthefaceof opinion.
Protocolon Biosafetyto theConvention
on BiologicalDiversity(2000)39 ILM
4 Cartagena
1027.At thetimeof theEC'swrittensubmissions,
therewere103signatories:
Biotech(n 2) para
4.340.TheProtocolenteredintoforceon 11 September
2003andtherearecurrently141parties:
see <http://www.cbd.int/biosafety/signinglist.shtml>
(lastaccessed20 July2007).
5 Biotech(n 2) paras7.92-7.94.
[ICLQvol 56, October2007pp 907-930]
doi: 10.1093/iclq/lei207
908
31(3)(c) of the Vienna Conventionon the Law of Treaties(VCLT)6in a novel way and,
with the consent of the disputing parties, consulted other internationalorganizations.
The result was that some politically contentious internationaltreaties and norms-includingthe Biosafety Protocol and the precautionaryprinciple7--were left out of the
report,while various rules and guidelines from standard-settingorganizationssuch as
the Codex Alimentariuswere takeninto account.The Panel's use of these international
rules and guidelines is easy to miss for those who limit their reading of the Panel's
1,000+-page reportto the 15 pages headed 'Relevance of other rules of international
law to the interpretationof the WTO agreementsat issue in this dispute';8in fact these
non-WTO sources were crucial to the Panel's analysis of the applicabilityof the relevant WTO covered agreements.
In this note, I explain and evaluatethe reasoningof the Biotech panel as it relatesto
the use of internationallaw norms extrinsic to the WTO.9First, I describe the Panel's
jurisdiction and its conception of the applicable law. Secondly, I turn to the Panel's
interpretationof the WTO obligationsaccordingto the rules enshrinedin the VCLT. In
this section, I explain the controversyover the Panel's interpretationof VCLT Article
31(3)(c). The Panel found that for treaties to be relevant rules of internationallaw
applicablebetween 'the parties',their membersmust be identicalto or broaderthanthe
WTO, thus attractingcriticismof under-inclusiveness.Next, I assess the Panel's use of
non-WTOsources as informingthe 'ordinarymeaning' of WTO treatytermspursuant
to VCLT Article 31(1). In taking this 'informative'law into account,the Panel did not
requireit to be binding between the disputingpartiesor the WTO members.Although
some would welcome this loosening of the requirementof State consent, I claim that
this methodof treatyinterpretationleads to 'over-inclusiveness'.To this end, I point to
examples from the Panel's reportwhere the Panel's incorporationof non-WTOsources
appearsindiscriminateand arbitrary.Thirdly,I consider how the Panel used its broad
consultativepowers to obtain informationfrom internationalorganizations.The Panel
linked this consultation with its quest to interpretthe 'ordinarymeaning' of treaty
terms. Again, the Panel did not inquireinto the levels of membershipof the disputing
partiesor the WTO Membersin the internationalorganizationswith which it consulted.
It did, however, closely involve the disputingpartiesin this consultativeprocess so that
their intentionsremainedrelevantto establishingan interpretativecontext of the WTO
treatyterms.
Underlyingmy critiqueof Biotech's use of relevantrules of internationallaw is the
need for visibility of certain assumptionsabout the 'internationalsystem' of international law. The Panel's interpretationof VCLT Article 31(3)(c) was founded on the
need to establish the consent of the constituentmembersof an internationalregime as
to its relevantinterpretativecontext. This interpretationfollows classic conceptionsof
sovereignty and establishes State consent as the 'entrancecondition' for relevantrules
6 ViennaConventionon the Law of Treaties(1969) 8 ILM679. Thereare
currently108
belown 42.
parties,manybutnotall of whomaremembersof theWTO.See further
7 Thatthesetreatiesandnormsarecontentious
is evidencedby thecurrent
forWTOMembers
betweenexistingWTOrules and multilateral
environmental
negotiationson the relationship
agreements(MEAs):see para 31(i) of the Doha Declaration,Doha Agenda Ministerial
20 Nov 2001 (2002)41 ILM746.
WT/MIN(01)/DEC/1,
8 ibidparas7.49-7.96.
law' and'non-WTO
(and,later,'non-WTO
sources')is not
9 My use of the word'extrinsic'
intendedto confirmthePanel'sstartingassumptions
aboutsources.
CurrentDevelopments
909
1. Overview
In 2003, the United States, Canada,and Argentinafiled a claim at the WTO relatingto
their attemptsto importgenetically modified agriculturalproductsinto the EC.11The
complaintscovered three generalcategoriesof measuresthataffected the approvaland
marketingof biotech products:12
* an alleged moratoriumby the EC on approvalsof biotech products;
* various EC measures affecting the approvalof specific biotech products such as
genetically modified maize ('product-specificmeasures');and
* various domestic 'safeguardmeasures' prohibitingthe importand/ormarketingof
specific biotech products adopted by particularEC Member States, viz, Austria,
France,Germany,Greece, Italy and Luxembourg.
The dispute was one of the most complex and wide-ranging in the WTO's 10-year
history. It took threeyears for the Panel to resolve and the resultingreportamountedto
over 1000 pages. In additionto the multiple submissions of the four disputingparties,
there were third-partysubmissions from Australia, Chile, China, New Zealand, and
Norway and three sets of amicus briefs from a group of universityprofessorsand two
groupsof NGOs. The Panel also obtainedwrittenand oral evidence from international
organizationsand scientific experts.
The complainingpartiesbased their claims on three WTO covered agreements:the
Agreement on Sanitary and Phytosanitary Measures (the SPS Agreement), the
10 ibidpara7.94:'themerefactthatoneor moredisputingpartiesarenotpartiesto a convenmeanthata conventioncannotshedlighton themeaningandscopeof a
tiondoesnotnecessarily
treatytermto be interpreted.'
relevancewerethosewhichwerein forceon orbefore
of primary
1l TheEClegalinstruments
of the Panelon 29 August2003, namelyDirective90/220on the
the dateof the establishment
of geneticallymodifiedorganisms([1990]OJL117/15)
deliberatereleaseintothe environment
of genetreleaseintotheenvironment
(repealed17Oct2002);Directive2001/19on thedeliberate
ically modifiedorganismsand repealingCouncilDirective90/220 ([2001] OJ L106/1) and
Regulation258/97concerningnovelfoods andnovelfood ingredients([1997]OJ L43/1):see
Biotech(n 2) para7.106.
12 See ibidpara7.98.
910
Agreement on Technical Barriers to Trade (the TBT Agreement) and the General
Agreementson TariffsandTrade(GATT).The SPS Agreement-which containsmore
onerous disciplines on import restrictionsthan the other two-requires countries to
undertakedetailedrisk assessmentsto justify as scientifically necessaryimportbans or
other trademeasures.One of the core issues of the case was thus the Panel's interpretation of the SPS Agreementto determineits applicabilityto the measuresin dispute
vis-a-vis the other two agreements.The Panel's jurisdictionto rule on these violations
was not disputedby the EC, althoughit did requesta preliminaryrulingon the breadth
of the parties' claims.13
In its defence, the EC claimed that three rules of internationalenvironmentallaw
were relevant to the dispute and should be used by the Panel as interpretativetools
First, the precautionary
according to the customary norms of treaty interpretation.14
should not be used as a
lack
of
full
scientific
that
which
certainty
provides
principle,
reason to postpone or avoid measuresto minimize novel and unprovenrisks of serious
or irreversibleharm,was said by the EC to be a generalprincipleof law. Secondly, the
Conventionon Biological Diversity (CBD),15which includes interalia a recognitionof
the precautionaryprinciplein its Preamble.Of the disputingparties,the EC, Argentina
and Canada were bound by the CBD, while the US had signed but not ratified it.
Thirdly,the EC invoked the Biosafety Protocol, which lays down requirementsfor the
transboundarymovement of 'living modified organisms'.16It had been ratifiedby the
EC but only Argentinaand Canadahad signed it and the US had no involvement with
it except for participationin the 'Biosafety Clearing-House'information-sharingmechanism. After a request by the Panel, the EC provided a list of provisions from these
MEAs that it consideredto be necessary for the Panel to take into account.17In addition to these principles of internationalenvironmentallaw relied on by the EC, there
was a large body of other internationallaw invoked variously by all of the disputing
partiesin theirsubmissions.This includedtreatiesand soft law instrumentsthatformed
the legal frameworkof internationalhealth and safety protectionsuch as Codex guidelines and FAO studies. I shall show in the next section that these materialswere to
become very relevantto the Panel's controversialtask of interpretingAnnex A of the
SPS Agreement.'8
The Panel releaseda confidentialinterimreportto the disputingpartiesin May 2006
(which was apparentlyimproperly disclosed to the public by one of them)19 and
13 ibid
para4.38.
14The WTOcoveredagreements
withcustomaryrulesof
areto be clarified'in accordance
law':DSUArt3.2.
of publicinternational
interpretation
190parties:see
on BiologicalDiversity(1992)31 ILM818.Therearecurrently
15 Convention
(lastaccessed20 July2007).
<http://www.cbd.int/convention/parties/list.shtml>
meansanylivingorganism
16 See BiosafetyProtocol,Art3(g):"'Livingmodifiedorganism"
thatpossessesa novel combinationof geneticmaterialobtainedthroughthe use of modern
biotechnology.'
refersto the
17Biotech(n 2) para7.95, see footnote274: 'The EuropeanCommunities
PreambleandArticle8(g) of the CBDandArticles1, 8, 10, 11, 15,23, 26 andAnnexIIIof the
BiosafetyProtocol.'
18 SPSAgreement
AnnexA is reproduced
below,n 40.
Eachpartystatedthattheyhadno involvement
19 The sourceof the leakwas not identified.
on
withtheleakandnotedtheirconcernsaboutit. Theinterimreportwassubsequently
published
the websitesof some of the NGOsthathad submittedamiciin the proceedings.See further
wasparticBiotech(n 2) paras6.183-6.196.China,as oneof thethirdpartiesto theproceedings,
see Minutesof
ularlyconcernedto bringthis leak to the attentionof the WTOmembership:
CurrentDevelopments
911
published its final public report in September2006. It found that the relevant legal
instrumentsconstitutingthe EC's approvalregime at the time of the establishmentof
the panel were SPS Measureswithin the meaningof Annex A of the SPS Agreement.20
It also found thatthe EC had operateda de facto moratoriumon the approvalof biotech
products.21Although this de facto moratoriumwas not itself a SPS Measure,22the
Panel found that it constituted 'undue delay' and thus violated certain procedural
requirementsof the SPS Agreement.23Similarfindings were made with respect to the
product-specificmeasures;24 out of the 27 challenged approvalprocedureswere said
to have been unduly delayed.24In addition, the Panel found that the Member State
'safeguardmeasures' fell within the definition of 'SPS Measures' in Annex A of the
SPS Agreement25and that there was a failure to conduct appropriaterisk assessments
before the impositionof these measures,in violation of the SPS Agreement.26It found,
too, thathaving disposed of the claims underthe SPS Agreementit was not requiredto
assess the complaintsunderthe TBT Agreementor the GATT.27The Panel reportwas
adoptedby the WTO Dispute SettlementBody in November 2006.28The EC did not
appealthe decision because althoughit disagreedwith some aspects of the findings, it
consideredthat much of the Panel reporthad become theoreticalbecause its approvals
regime had been functioningnormallyand some 10 GM productshad been authorized
since the Panel's establishment.29
2. Applicable law
Before assessingthe Panel's use of non-WTOsourcesas interpretativetools, it is importantto note thatthe EC did not claim thatthe rules of internationallaw enshrinedin the
precautionaryprinciple,the CBD and the Biosafety Protocolshouldbe directlyapplied
(12 Jan
Meetingof the WTODisputeSettlementBodyof 21 November2006,WT/DSB/M/222
2007)para74.
20 ThePanelfoundthatthe
form,nature,andpurposeof Directives90/220and2001/18as well
as Regulation
258/97(to theextentthatthatRegulation
soughtto preventnovelfoodsfrombeing
a dangerto theconsumer)constituted
'SPSmeasures'withinthemeaningof AnnexA(1) of the
SPSAgreement:
see Biotech(n 2) paras7.147-7.437,especiallypara7.432.
21 ibid,paras7.438-7.1627,
especiallypara7.1272.
22 ibid, para7.1383. The complainingpartiesthus failed to establishthatthe moratorium
breachedArts5.1, 5.6 and2.2 of theSPSAgreement.
23 The relevantobligationswere in Annex C(1)(a)and, consequently,Art 8 of the SPS
see 7.1567-7.1568.Thecomplaining
Agreement:
parties'claimsunderArts2.2, 2.3, 5.1,5.5, 5.6,
7, and10.1andAnnexB(1) andAnnexC(1)(b)wererejected.
24 See Biotech(n 2) paras7.1628-7.2528.TheEC was foundto havefailedto completethe
relevantapprovalwithoutunduedelay and hence had breachedits obligationsunderAnnex
see summary,
C(1)(a),firstclause,andArt8 of theSPSAgreement:
paras7.2390-2391.Formore
detailsee, eg, the approvalprocedurefor Falconoilseedrape:para7.1813.The complaining
parties'claimsunder2.2, 2.3, 5.1, 5.5, 5.6, 7, AnnexB(1),AnnexC(1)(b),(c) and(e) of theSPS
wererejected.
Agreement
25 See Biotech(n 2) paras7.2545-7.2922.
26 Therelevantobligationswerein Arts5.1 and,by
thesecondandthirdrequireimplication,
mentsof Art2.2 of theSPSAgreement:
see generallyparas7.3008-7.3399.ThePanelexercised
judicialeconomyon Arts2.3, 5.5 and5.6 of theSPSAgreement.
27 See,forthesafeguard
measures,Biotech(n 2) paras7.3407-7.3430.
28 Minutesof Meetingof the WTO DisputeSettlementBody of 21 November2006,
WT/DSB/M/222
(12 Jan2007).
29 ibid para73.
912
law:'Suchinternational
law applies
international
May2000)para7.96 withrespectto customary
out"fromit. To putit anotherway,
to theextentthattheWTOtreatyagreements
do not"contract
or anexpressionin a coveredWTOagreement
to theextentthereis no conflictor inconsistency,
lawapplyto
thatimpliesdifferently,
we areof theview thatthecustomary
rulesof international
undertheWTO.'See furtherD Palmeter
theWTOtreatiesandto theprocessof treatyformation
and PC Mavroidis,'The WTOLegal System:Sourcesof Law' (1998) 92 AJIL398, 409; L
Lawin WTODisputeSettlement
Bartels,'Applicable
(2001)35(3)J of WorldTrade
Proceedings'
499; J Pauwelyn,ConflictofNorms in Public InternationalLaw (CUP, Cambridge,2003) 460 and
Products,WT/DS58/AB/R,
adopted6 Nov 1998,DSR 1998:VII,2755.
36 Biotech (n 2) para7.72.
CurrentDevelopments
913
914
measures that fall within the disciplines of the SPS Agreement.4 The meaning of
Annex A was therefore central in determiningthe applicabilityof the more onerous
disciplines of the SPS Agreementvis-A-visthe TBT Agreementand the GATT. Terms
like 'pests', 'diseases' and 'toxins' were hotly contestedin the parties' submissions as
to whetherthe EC approvalregime and the safeguardmeasuresto protectagainstrisks
posed by biotechnologywere 'SPS measures'.The meaningof otherWTO treatyterms
such as 'likeness' (ie whetherGM and non-GMwere 'like products'),'risk assessment'
(whether the EC proceduressatisfied the relevant risk assessment requirements)and
'unduedelay' (in assessing the time takenby the EC to approvebiotech products)were
also contestedby the parties.
To determinewhether relevant rules of internationallaw could assist in the interpretationof these treatyterms,the Panel had to follow customarynormsof treatyinterpretation,41which are codified, at least in part,by the VCLT.42The Panel separatedits
task of treatyinterpretationinto two stages. The first stage, isolated early in the report
and deliveredin the 15 pages mentionedabove,43relatedto the use of Article 3 1(1) and
31(3)(c) of the VCLT in determiningwhetherthe CBD, Biosafety Protocolandprecautionary principle were relevant to this dispute. The second stage was the Panel's
substantiveinterpretationof Annex A of the SPS Agreement,which it undertookusing
a wide variety of interpretativetechniques and extrinsic sources of internationallaw,
ostensibly in ascertainingthe 'ordinarymeaning' of treaty terms according to VCLT
Article 31(1). In my view, the Panel separatedits reasoning in this way because of
sensitivities relating to the WTO's treatmentof internationalenvironmentallaw, an
issue of enduringpolitical disagreement.44
1. VCLTArticle 31(3)(c) and 'theparties'
VCLT Article 31(3)(c) allows a treaty-interpreter
to take into account'relevantrulesof
internationallaw applicablein the relationsbetween the parties'.The Panel agreedthat
'rules of internationallaw' could encompass treaties,customaryinternationallaw and,
drawingon US-Shrimp,general principlesof law. As such, it agreed that a treatylike
the Biosafety Protocol would qualify as a rule of internationallaw. So too the precaumeasure-Any
40 AnnexA:1 of the SPS Agreementreads:'1. Sanitaryor phytosanitary
measureapplied:(a) to protectanimalor plantlife or healthwithintheterritory
of theMember
fromrisksarisingfromthe entry,establishment
or spreadof pests,diseases,disease-carrying
(b) to protecthumanor animallife or healthwithinthe
organismsor disease-causing
organisms;
of theMemberfromrisksarisingfromadditives,contaminants,
toxinsor disease-causterritory
in foods,beveragesorfeedstuffs;(c) to protecthumanlife orhealthwithintheterriingorganisms
thereof,
toryof theMemberfromrisksarisingfromdiseasescarriedby animals,plantsorproducts
orfromtheentry,establishment
or spreadof pests;or (d) to preventorlimitotherdamagewithin
theterritory
of theMemberfromtheentry,establishment
or spreadof pests'.
41 DSU Art 3.2 (n 14).
CurrentDevelopments
915
tionary principle, if established as a general principle of law. The sticking point was,
however, the need for such rules to be 'applicablein the relationsbetween the parties'.
The Panel ruled that 'the parties' meant all the parties to the WTO, ratherthan 'the
disputingparties' or 'one or more parties'.45It found:
Thisunderstanding
of the term'theparties'leadslogicallyto the view thatthe rulesof
law to be takenintoaccountin interpreting
international
theWTOagreements
at issuein
thisdisputearethosewhichareapplicable
in therelationsbetweentheWTOMembers.46
The Panel then pointed to the evidence that the CBD and Biosafety Protocol did not
have the same coverage of membersas the WTO covered agreements;in particular,the
fact that the US had not ratified either.47Moreover, after reviewing recent cases and
commentaryon the precautionaryprinciple,including the Appellate Body's refusal to
take a position on its status as a principleof general or customaryinternationallaw in
the 1998 EC-Hormones decision,48the Panel declined to rule on whetherthe precautionary principle could constitute a relevant rule of internationallaw according to
Article 31(3)(c). The Panel thus disposed of the need to take into accountany relevant
rules of internationallaw accordingto VCLT Article 31(3)(c).
The termsof the VCLT lend compelling supportto the Panel's finding thatrelevant
rules must be applicableto all the partiesto the treatybeing interpreted.VCLT Article
2, for example, defines 'party'as 'a state which has consentedto be boundby the treaty
and for which the treaty is in force'. In addition,the VCLT is intendedto be applied
generallyas well as to disputes.49Moreover,if one considersthe WTO covered agreements to representa 'packagedeal' which is not subjectto reservation,it would follow
thatthe treatiescannotmean differentthings for differentparties.As such, 'consent' of
the entire WTO membershipis a necessary 'entrancecondition' for treatiesthat are to
be relevant as interpretativetools. However, the Panel's approachto Article 31(3)(c)
departedfrom the bulk of the submissionsto it. The complainingpartieshad proceeded
on the basis that 'the parties' meant 'the disputing parties',50 although Canada later
amendedits approach.51The only thirdpartyto make a submissionon this matteralso
focused on the disputingparties.52This understandingof 'the parties' as parties 'to the
dispute' has also been advancedby several commentators.53
One of the main reasons to prefer a readingof Article 31(3)(c) as referringto 'the
disputingparties' is because the alternativeinterpretationrendersit ineffective.54The
45 Biotech(n 2) para7.68.
46 ibid.
47 ibid,paras7.74-7.75.
48 AppellateBodyReport,EC Measures
MeatandMeatProducts(Hormones),
Concerning
WT/DS26/AB/R,
WT/DS48/AB/R,
adopted13 Feb1998,DSR 1998:1,135.
49 McLachlan
(n 31) para16. Thispointwas madeby thePanel,whichnotedthatArticle31
did notpurport
to lay downrulesof interpretation
'whichareapplicablesolelyin thecontextof
international
(quasi-)judicial
proceedings'.The Panelcontrastedthis with VCLTArticle66,
whichdealswithprocedures
forjudicialsettlement,
arbitration
andconciliationandmakesreferenceto 'thepartiesto a dispute':see Biotech(n 2) para7.68,footnote241.
of theUnitedStatesatBiotech(n 2) para4.543;SecondWritten
50 SecondWrittenSubmission
Submissionof Canadaat Biotech(n 2) para4.600;SecondWrittenSubmissionof Argentinaat
Biotech(n 2) para4.688.
51 Biotech(n 2) para7.60.
52 ThirdPartyOralStatement
of Australia,
ibidpara5.12.
53 PalmeterandMavroidis(n 31) 411. Thisis alsoimplicitin Marceau(n 32) 1087.
was consideredby the ILCto be implicitin the
54 The principleof effectiveinterpretation
916
Panel'sconceptionthattreatiesmustbe applicable
to allWTOMembersrequires
parallels in treatymembership
thataremostlyunrealistic,
especiallywhenthetreatyunder
Inaddition,expressinter
extendsto non-Stateactors,as doestheWTO.55
interpretation
se modification
of WTOobligationsby onlysomeof thepartiesis permitted
underthe
VCLT.56On this basis, some arguethatrecourseto suchinterse agreementsin the
of therelevantWTOagreementshouldnotbe excludedby a restrictive
interpretation
readingof Article31(3)(c).57Moreover,forthoseconcernedaboutthe 'systemicintethatrelevantrulesof international
law
law, the requirement
gration'of international
needto be 'applicablein relationsbetweenWTOMembers'in orderto qualifyunder
Article31(3)(c)will resultin the 'isolation'of multilateral
as 'islands'and
agreements
be contraryto theintentof treaty-makers.58
It wason thisbasisthattheILCStudyGroup,commenting
on theinterimreportin
Biotech,was so criticalof the case.59The StudyGrouppreferredan approachthat
The risksof divergent
of the disputingparties.6?
emphasizedthe treatymembership
wouldbe mitigated,accordingto the StudyGroup,in two ways.First,
interpretations
thetreaty-interpreter
woulddifferentiate
between'synallagmatic'61
treatiesthatcreated
merelyreciprocalobligationsbetweentreatypairsandtreatiesthatweremore'interdependent'or 'collective',whichcreatedobligationsowedergaomnespartes.Forthe
formertype,divergencein treatyinterpretation
for sets of disputingpartieswouldbe
the
latter
the
For
coherenceof thetreatywouldneedto
however,
unproblematic.
type,
be protected
theuseof othertreatiesin interpreting
its terms.62
by restricting
Secondly,
theStudyGroupconsidered
thata treaty-interpreter
shouldtakeintoaccounttheextent
to whichanotherrelevanttreatycouldbe saidto havebeen 'implicitly'acceptedor
toleratedby other parties,notwithstanding
non-identicalmembership.63
The final
conclusionsof the ILC StudyGroupreflectedthis secondqualification.64
The ILC
of goodfaithin accordance
doctrine
of interpretation
withtheordinary
of thetext,and
meaning
wastherefore
notgivenseparate
in theVCLT:see [1996]Ybkof theInternational
Law
expression
Vol II, p 219, para6. Forfurtherreferencesto theAppellateBody'sapplication
Commission
of
theprinciple,see Korea-DefinitiveSafeguardMeasureson Importsof CertainDairyProducts,
WT/DS98/AB/R,
p 24.
whicharesimplyunable
55 The 'partiesto theWTOAgreement'includecustomsterritories,
to be partiesto treatieslike theCBD,thusrendering
Art31(3)(c)inutileif it canonlybe applied
to treatiesof identicalmembership.
theVCLTin thelightof the (differOf course,interpreting
to interpretation
too far.
ent)partiesto theWTOmightbe takinganevolutionary
approach
56 VCLTArt41. See alsoVCLTArt30 and59.
57 L Bartels,'ArticleXX of GATTandtheProblemof Extraterritorial
Jurisdiction'
(2002)36
J of WorldTrade353, 360-1. Bartelsconsidersthat,unliketheEC,theWTOsystemis founded
on regulatory
of WTOrules:ibid.
diversityanddoesnotcall fortheuniforminterpretation
58 Reportof theILCStudyGroupas finalizedby Koskenniemi
(n 1) para471.
59 ibid para450: 'Thepanelbuyswhatit calls the "consistency"
of its interpretation
of the
WTOTreatyatthecostof theconsistencyof themultilateral
treatysystemas a whole.'
60 ibidpara472: 'A bettersolution[fortheuseof treatiesunderVCLTArticle31(3)(c)]is to
permitreferenceto anothertreatyprovidedthatthepartiesin disputearealsopartiesto thatother
61 ibid.
treaty.'
CurrentDevelopments
917
918
CurrentDevelopments
919
considerationto various provisions of the CBD and the Biosafety Protocol on this
basis. It concluded that it did not find it 'necessary or appropriateto rely on these
particularprovisions in interpretingthe WTO agreementsat issue in this dispute'.82
Materialsthat did assist the Panel in interpretingcertain terms of Annex A of the
SPS Agreement, in accordancewith VCLT Article 31(1), were said to be reference
materialsprovided to it by several internationalorganizations,namely Codex, FAO,
the IPPCSecretariat,
andUNEP.83Thesematerials
WHO,OIE,the CBD Secretariat
included conventions, standardsand guidelines of these internationalorganizations,in
additionto glossaries andreferenceworks.84The Panel had consultedwith these internationalorganizationsduringthe course of the dispute.85It was this body of materials
that informed the Panel in its far-reachinginterpretationof Annex A of the SPS
Agreement, which formed the bulk of its reasoning on the applicability of the SPS
Agreementto this dispute.
The Panel's approachto VCLT Article 31(1) is logically attractivegiven that 'ordinary meaning' is not a matterof consent, but ratherof intersubjectivity.Meaning in
languageis not dependenton the consent of participants,but ratherdevelops according
to social practices within a community. Given the implied reliance on the concept of
an internationalcommunity, the Panel's approachmay seem appealing to those who
call for the systemic integrationof internationalnorms.86It negates the need to establish the consent of treatypartieswhen taking into account other treatiesthat, notwithstanding dissimilar treaty membership from the treaty being interpreted, are
representativeof 'ordinarymeaning'. Of relevanceis not whetherWTO membershave
ratified the relevantrule, but whether it is 'informative'by dint of its representativeness of ordinarymeaningwithin the internationalcommunity,or, at least, to the treatyinterpreter.The following section will examine this notion of 'informative'rules and
analyse the Panel's use of them. But first it is importantto ascertainthe doctrinalbasis
for the Panel's approach.
(a) Doctrinal supportfor the use of extrinsic materials to interpreta treaty term in
accordance with its 'ordinarymeaning'
The Panel claimed doctrinal support for its use of VCLT Article 31(1) from
US-Shrimp,in which the Appellate Body used relevantrules of internationallaw for a
numberof interpretativepurposes,without ascertainingwhethersuch rules were binding on the disputingpartiesor, indeed, the WTO membershipas a whole. In determining, for example, whether the term 'exhaustible naturalresources' in Article XX (g)
GATT 1994 included endangeredturtles,the Appellate Body consideredthat the text
was not determinativeand sought the aid of interpretativetools.
The Panel's pigeon-holing of the Appellate Body's reasoning to VCLT Article
31(1) is questionable. In US-Shrimp, the Appellate Body did not refer directly to
82 ibid,para7.95.
83 ibid,para7.96.
85 See PartD below.
84 ibid.
86 McLachlan
(n 31) para17: 'referencemayproperlybe madeto othertreaties,evenif they
arenot in forcebetweenthe litigatingparties,as evidenceof the commonunderstanding
of the
to theoverallrequirement
partiesas to themeaningof thetermsused.Thismaybe donepursuant
of Article31(1)to considertheobjectandpurposeof thetreaty.'Butsee Reportof theILCStudy
Groupas finalizedby Koskenniemi(n 1) para450: 'taking"othertreaties"into accountas
evidenceof "ordinary
the"clinicalisolameaning"
appearsa rathercontrivedwayof preventing
tion"as emphasized
by theAppellateBody.'
920
in substantial
termshis 'A Noteon theDoctrine
A Prager,New York,1958)52-60, reproducing
Law:(1950)42
to theInstituteof International
of "PlainMeaning"'(1950),whichhe submitted
natureof meaninghasbeena preoccuAnnuear377-90. Indeed,thecontextualandcontestable
as
pationof manydisciplinesof academicthought.Mostnotably,theideabehinddeconstruction,
foundforexamplein theworksof Derrida,is thatwordsortermsalwaysandnecessarilydeferto
otherdifferenttermsin a conceivablyendlessprocess.
CurrentDevelopments
921
imposed by the system itself. In the VCLT, the allowable context is narrowlydefined
by Article 31(2) as the body of textual materialgeneratedduringthe conclusion of the
treaty.96Accordingto the rest of the VCLT's rule of interpretation,the only otherrelevant extrinsic materials are those developed subsequentlyby the parties evidencing
their common intentions,(includingwith respect to a 'special meaning' to be given to
a term),97and supplementarymeans where interpretationunder Article 31 leaves the
meaning 'ambiguous or obscure' or leads to a result 'which is manifestly absurdor
unreasonable'.98Thus other extrinsic materials,such as informativeinternationallaw
materials and even, perhaps,dictionaries,are not considered to be relevant to establishing 'ordinarymeaning'. These contextual boundarieswere ignored by the Panel,
which insteadsought guidancefrom 'informative'texts to bringto an end its searchfor
'ordinary
meaning'.
In my view, the Panel would have been more convincing if it had relied on the
purposiveelement of VCLT Article 31(1) ratherthan its referenceto 'ordinarymeaning'. Treaties that are not binding on all WTO Members may still be relevant, for
aboutthe object and purposeof a treaty.99The
example, to inform a treaty-interpreter
object and purposeof a treatyregulatingthe apple tradewill be more easily found to
exclude the orange trade if a substantialpredecessor treaty exists for the trade in
oranges, even if membershipof the two treaties is not identical. On this reading, the
fact that the CBD parties, most of whom are WTO members, were negotiating a
Protocol on Biosafety at the time of the SPS Agreementcould be rebuttableevidence
that the object and purposeof the SPS Agreementwas to exclude rules and disciplines
on SPS measuresaimed at biotech products.100The principlesof 'sustainabledevelopment' and 'mutualsupportiveness'that have been endorsedby WTO memberswould
also be relevantto this purposiveinquiry.101
96
meansto interpret
thephrase'ordinary
Althoughit mayseemoddto turnto supplementary
ontheVCLT.
meaning',I notethatthisreadingis confirmed
by referenceto theILCCommentary
TheILCdidnotappearto anticipate
thatthe 'ordinary
meaning'wouldnecessitatethereference
to any extrinsic texts beyond those texts that established the 'context' of the treatyin Art 31(2):
(eds),
integrativenatureof this principle:see MC CordonierSeggerand CG Weeramantry
Sustainable Development: Reconciling Economic, Social and EnvironmentalLaw (Martinus
Nijhoff, The Hague, 2004), which I reviewed in (2007) 56 ICLQ209. On 'mutualsupportiveness'
see below n 150 and surroundingtext.
922
the TBT Agreement or the GATT-to the challenged measures of the EC and its
106SPSAgreement,
AnnexA (a),(c),(d).
CurrentDevelopments
923
basis, GM plants were considered 'pests' within the meaningof Annex A in situations
where they did not cause injurybut, for example, grew where they were undesired.111
This interpretationwas to have profoundeffects for the wide applicabilityof the SPS
Agreementto the EC Member-Statesafeguardmeasureson biotech products.112
A second example of the Panel's reasoning is drawnfrom its interpretationof the
term 'diseases', which featuredin Annex A with respect to animals or plants. The EC
cited the definition of the World Organizationfor Animal Health (OIE) that disease is
'the clinical and/orpathological manifestationof infection'. This definition supported
its argumentthat its biotech approval regime did not address the risks identified in
Annex A because GMOs were not diseases or disease-carryingorganisms. As one of
the standard-settinginstitutionsrecognized by the SPS Agreement,I consider that the
OIE was well chosen as representativeof the internationalhealth and safety context for
animals and plants. However, the Panel instead turnedto the dictionarydefinition of
disease as a 'disorder'and drew also on the World Health Organization(an organization aimed at human ratherthan animal health). On the basis of this wide reading of
'disease', the Panel concluded that an approvalregime that sought to avoid adverse
effects that might arise from the deliberate release of GMOs into the environment
constituteda measureapplied to protect animal or plant life or health from risks arising from disease.113
Furtherexamples of the Panel's reasoningcan be identified from the Panel's interpretationof Annex A(1)(b) of the SPS Agreement,which covers measuresapplied 'to
protect human or animal life or health within the territoryof the Member from risks
arising from additives, contaminants,toxins or disease-causing organisms in foods,
beverages or feedstuffs'.114The third example of the seven listed here relates to the
Panel's reasoning as to whetherthe challenged measuresrelated to 'foods, beverages
or feedstuffs'. The EC submittedthat GM seeds used in agriculturewere not covered
by this provision.115The Panel referredto the dictionarydefinition of 'food' as nutrition for humans or animals (without considering the object and purpose of the SPS
Agreement with respect to food safety) and consideredthat, for example, if the pollen
from a GM crop was consumed by an insect or if a GM plant was consumed by deer,
this would be consideredas 'food'.116On the basis of this finding, the Panel found that
several of the Member-Statesafeguardmeasuresfell within Annex A(1)(b).117
The fourthexample relates to the Panel's determinationthat the EC's measureson
biotech productsamountedto protectionfrom 'additives'. Codex defines an additiveas
a substancethatis addedto 'food', ratherthan a substancewhich is addedto plants and
which may find its way into food. The EC submittedthat this definition was determi-
included'situationsof unintentional
geneflow or transfer
111 ibidpara7.242.Othersituations
betweenGMplantsandotherplants
froma GMOplant("out-crossing")
leadingto cross-breeds
... GM
traits"'and 'situationswherepesticide-producing
... whichhaveundesiredintroduced
in targetorganisms,
plantsincreasethe potentialfor the developmentof pesticide-resistance
notablyinsects'.
112 See ibidparas7.2677-7,2678(Austria);
para7.2726(France);paras7.2787-2788;7.2791
andparas7.2828,7.2833(Greece).
(Germany);
para7.2906(Luxembourg);
113 Biotech(n 2) paras7.277-7.278.
114Aboven 40.
"115
Biotech(n 2) para7.288.
116ibidparas7.291-7.292.
117 ibidparas7.2630,7.2676(Austria),
para7.2837(Greece).
para7.2786(Germany);
924
native that the GM productsrelevantto the dispute were not 'additives'.118The Panel
noted thatthe incorporationof Codex standardsby the harmonizationprovisionsof the
SPS Agreement did not mean that Codex definitions were necessary to take into
accountin ascertainingthe meaningof Annex A terms.119It drew insteadon the dictionary definition of an additive as 'a substanceadded to anotherso as to give it special
qualities'120and concluded that genes intentionallyadded to GM plants (where the
plants are to be eaten) can be consideredas additives.121
Fifthly, the Panel adoptedsimilar reasoningwhen it found that the term 'contaminants' covered broadersituationsthanenvisaged by the relevantCodex definition.The
Panel extendedthe term to 'proteinsunintentionallyproducedin GM plants which are
eaten or used in the productionof food or feedstuffs'.122Sixthly, the Panel drew on the
dictionary definition of 'toxin' in addition to definitions from the Codex and the
FAO123as supportfor its propositionthat toxins did not necessarily have to be added
unintentionallyto foods; the fact that a GM plant (earlier defined as 'food') might
intentionallyproducea toxin to ward off insects did not remove it from the definition
of toxin in Annex A(1)(b). As a final example,124the Panel consideredthat this definition of 'toxin' was also relevant to the EC's targetingof the risk that GM products
might give rise to allergicreactions.In assessing whetherthis aspectof the EC approval
regime constitutedan SPS measure,the Panel noted thatthere is no referenceto 'allergens' as one of the groundsof risk in Annex A(1)(b). It noted that the draftersof the
SPS were aware of food allergenicityconcerns,125but consideredthat the absence of
the term 'allergens' did not 'reflect a deliberatechoice to exempt food allergenicity
risks from the scope of the SPS Agreement'.126Instead, the Panel found that the
draftershad consideredfood allergensto fall within 'toxins'.127For this interpretation,
the Panel relied on the dictionary and a definition of allergen as 'an antigen that
provokes an immune response"' from the FAO Glossary of Biotechnology for Food
and Agriculture.128The Panel considered that food allergens were akin to poisonous
substances in the harm they could cause to humans; as such, they could fall within
Annex A(1) as 'toxins'.129For allergic reactionscaused by exposure to GM unrelated
to food consumption,the Panel drew on its earlierinterpretationof the IPPCanddictionary definition of 'pest' and found that 'to the extent that a GM plant produces allergenic effects otherthan as food, it would be a plant which causes harmto the healthof
humansand, as such, would qualify as a "pest"'.130
These seven examples demonstratethat an approachthat draws on extrinsic materials to informan 'ordinarymeaning' of a termmay lead to de-contextualizedand arbitraryreasoning.The Panel failed to meet the challenge of moving beyond the abstract
meanings of the terms in Annex A towards a disciplined and reasoned use of other
126 ibid.
122ibidparas7.305-7.316
123ibidpara7.321.
124Therearemanyotherexamplesof thePanel'sinterpretation
of AnnexA terms:see, eg, ibid
paras7.147-7.437.
128ibidpara7.334.
127ibid.See alsopara7.337.
129 Thisreasoning
was appliedto theAustriasafeguard
measureon B-176:ibidparas7.2643,
7.2783.
130 ibid
para7.350.
CurrentDevelopments
925
D. TakingAccountof RelevantRulesthroughConsultation
As alreadynoted, the Panel obtainedmuch of the extrinsicmaterialthat was to become
relevantto its interpretationof Annex A termsthroughconsultationswith international
organizations.133In fact, the Panel obtained informationfrom a range of individuals
and bodies, which fell broadlyinto three groups:internationalorganizations,scientific
and technical experts and those interested parties who filed amicus briefs.134The
empoweringprovisionsfor these consultationswere cited as Article 13.1 DSU, Article
11.2 SPS Agreement, Articles 14.2 and 14.3 TBT Agreement, and, in the case of the
amici, the Panel's broaddiscretion.135
131 Foran accountof thatchallenge,see SecondWrittenSubmissionsof the EC, ibid
para
4.748: 'it is clear that the "commonand ordinary"meaningapproachadvocated,in some
instances,by thecomplaining
definitions,wouldnot
parties,to theexclusionof theinternational
be sufficient.Thecommonlanguagedefinitionsof SPStermsareoftenso vagueandbroadas to
depriveof anymeaningthe categoriesanddistinctionsset out in AnnexA.1. Forinstance,the
definitionproposedby theUnitedStatesof theterm"toxin"("anysubstancewhich,whenintroducedintoorabsorbed
by a livingorganism,
destroyslife orinjurieshealth")is capableof encompassinganything,froma chemicalresidueto a leadbullet.'
132 Specialregard
familiarto manyadministrative
maybe hadto principles
lawyers,suchas the
of failuresby decision-makers
to takerelevantconsiderations
intoaccount.
judicialreviewability
133 Biotech(n 2) para7.96, aboven 83 andsurrounding
text.
134 As described
to the Panel;one was froma
above, threeunsolicitedbriefsweresubmitted
groupof universityprofessorsandtheothertwo werefromcoalitionsof NGOs.
135Biotech(n 2) para7.11,citingUS-Shrimp.
926
CurrentDevelopments
927
928
E. Conclusion
The dispute over trade in certainGM productsarose within a diffuse institutionaland
normativecontext. This context involved the WTO covered agreements,multilateral
environmentalagreementssuch as the CBD and Biosafety Protocol,internationalstandards of bodies such as IPPC and Codex and the alleged general principleof precaution. Once filed at the WTO, the question for the Panel was how much regardit could
have to these bodies of law, many of which were not binding on the disputingparties
or the WTO members as a whole. This note has examined the way the Panel utilized
these non-WTO sources by assessing the applicablelaw and interpretativetools identified by the Panel and its institutionalmechanismsfor consultation,particularlywith
internationalorganizations.
In summary,the Panel restrictedthe use of non-WTOlaw by:
155 Biotech(n 2) para7.300.
156SPSAgreement
AnnexA.3.
157TBTAgreement
158Sardines(n 138)
Annex1:4.
para225.
159 Decisionof the Committee
on Principlesfor the Development
of International
Standards,
GuidesandRecommendations
withrelationto Arts2, 5 andAnnex3 of the Agreement.
These
principlesare foundin SectionIX of the Decisionsand Recommendations
adoptedby the
Committeesince 1 January1995,G/TBT/1/Rev.
8, 23 May2002 ('Inorderto improvethequalstandardsand to ensurethe effectiveapplicationof the Agreement,the
ity of international
Committee
agreedthattherewasa needto developprinciples
concerning
transparency,
openness,
andconsensus,relevanceandeffectiveness,
coherenceanddevelopingcountryinterimpartiality
eststhatwouldclarifyandstrengthen
theconceptof international
standards
undertheAgreement
andcontribute
to theadvancement
of its objectives.')
160 Therehasbeena long-standing
requestby theCBDandtheBiosafetyProtocolforobserver
see further
J Scott,The
statusto theSPSCommittee,
whichhasbeendelayedon politicalgrounds:
WTOAgreementon Sanitaryand PhytosanitaryMeasures:A Commentary(OUP, Oxford, 2007)
63.
161 I notethattheILCStudyGroup'smandate
didnotextendto a consideration
of institutional
issuesrelevantto thefragmentation
anddiversification
law:see Reportof theILC
of international
(n 1) para13.
StudyGroupas finalizedby Koskenniemi
CurrentDevelopments
929
* merging the complaints of the complainingparties. This limited the applicable law
to law binding on all four disputing parties, in the sense that the CBD, which was
binding on three of the disputingparties,was not applicable;162
* construing'the parties' in VCLT Article 31(3)(c) as 'the partiesto the treaty' rather
than 'the disputingparties'.As a result,the Panel could not take accountof 'relevant
rules of law applicablein the relationsbetween the parties'in its interpretationof the
relevantWTO agreementsunless they had identical membershipto the WTO; and
* closely involving the disputingpartiesin its consultationswith internationalorganizations and scientific experts, notwithstandingits broad ability to seek information
underthe DSU.
On other hand, the Panel expandedits ability to take into account non-WTOlaw by:
* drawing on non-WTO sources if they were informativeof the 'ordinarymeaning'
of WTO treatyterms accordingto VCLT Article 31(1).
The first set of strategic and doctrinaldecisions identified above engenders the criticism thatthe Panel was overly restrictivein its use of non-WTOsources. On this basis,
the Panel's later constructionof VCLT Article 31(1) as allowing for the incorporation
of a wide body of non-WTOlaw will be welcomed. Treatieswere found to be relevant
if they could be consideredas demonstrativeof the 'ordinary'meaningof certainWTO
terms, regardlessof the degree to which the WTO memberswere bound by them. Yet
I have demonstratedthat, quite apartfrom the questionabledoctrinal foundationsof
this readingof VCLT Article 31(1), its applicationcan lead to highly abstractnotions
that are de-contextualizedfrom disputes.The Panel's attemptto 'unmask'the termsof
Annex A of the SPS Agreementin a depoliticized, 'natural'investigationthat picked
and chose between dictionariesand rules of internationallaw was fraught.
Of the many implications of my analysis, two may be identified here. First, if the
consent of the disputingpartiesor the WTO membersis not requiredfor a treatyto be
taken into account underthe norm of treatyinterpretationin VCLT Article 31(1), it is
importantto shed visibility on its substitute. For the Panel, this substitute was the
'informative'natureof a relevantrule of internationallaw. Implicit in this approachis
the notion of an 'internationalsystem' or 'internationalcommunity' providing the
context for an assessment of the rule's relevance. Questions must be asked about any
biases thatresult from this conceptionof the internationalcommunity.For example, in
Biotech this 'internationalcommunity' was a scientific and technical communitythat
had been active in developing rules and guidelines. Yet absence of rule-makingby
partsof this scientific communitymay be attributedto an absence of scientific inquiry
(due to divertedresearchfunding,epistemic weaknesses, etc) ratherthanan absence of
collective concern. Silence in the internationalsystem may be 'informative'for many
reasons. Moreover, given that all the disputing parties argued at various points that
there was 'consensus' for the interpretationthat they were advancing,there is a need
for the Panel to assess (and even rank) 'degrees' of consensus in ways other than
simply pronouncingon what seems the most 'informative'.
930
This criticism points more generally to the second majorimplication of my analysis: the need to think critically and creatively about the types of 'entranceconditions'
for norms in internationaldispute settlement.For example, institutionalrelationships
already exist between the WTO and other internationalorganizations.In this note I
have pointedto some of the ways that standard-settingbodies are incorporatedinto the
WTO frameworkif they accord accessibility to all WTO members.Such accessibility
might be a factorin determiningwhethera WTOpanel shouldtake accountof the work
The breadthof an organization'ssupport,and its balanceof its
of that organization.163
membershipbetween developing and developedcountries,164mightbe otherfactors.165
Procedures for transparencyand cooperation between secretariats,and openness to
non-Stateactors such as NGOs, might be furtherfactors that reinforcethe 'relevance'
of the norms developed underthe auspices of internationalorganizations.These ideas
call into questionthe currentjudicial tools of interpretationand consultation.For example, to allow for such radical 'entrance conditions' for internationalnorms in treaty
interpretation,panels may need to consult with other internationalinstitutions in a
proactiveway thatdoes not rely on the disputingparties.166Moreover,the VCLT itself
could be interpretedin an evolutionaryfashion to incorporatea spectrumof 'international consensus' as opposed to binary questions of consent and non-consent.
Recognizing the increased involvement of internationalorganizationsand non-State
actors in law-making adds a further shade to this spectrum and allows institutional
questions of openness and accessibilityto be raisedat the interpretativestage. As such,
the process by which a treatycomes into being may be assessed to determineits probative value in interpretingothertreatyobligations.These ideas would have benefitedthe
Biotech panel and will be increasingly useful to the fragmentedinternationallegal
order.
MARGARET
A YOUNG*